• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>VASA: Zeitschrift fuer Gefarsskrankheiten. Journal for vascular diseases >Power-injectable totally implantable venous access devices - analysis of success and complication rates of ultrasound-guided implantation and a patient satisfaction survey
【24h】

Power-injectable totally implantable venous access devices - analysis of success and complication rates of ultrasound-guided implantation and a patient satisfaction survey

机译：可重新注射的完全可植入的静脉接入装置 - 超声引导植入的成功和复杂性率和患者满意度调查分析

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: To retrospectively evaluate the success rates, peri-interventional, early and late complications and patient satisfaction associated with power-injectable totally implantable venous access devices (TIVAPs). Patients and methods: Between April 2011 and March 2016, a total of 1,203 TIVAPs were implanted in 1,169 patients. Ultrasound-guided, fluoroscopically controlled implantation was performed through the subclavian or internal jugular vein. The systematic analysis focused on the rate of successful port implantations, the frequency of peri-interventional, early and late complications and on how the experience of the implanting radiologist impacts these parameters. Additionally, a standardized questionnaire was administered to the 102 study patients in a telephone interview to survey their subjective rating of the port implantation. Results: 99.5 % of TIVAPs were implanted successfully. In 4 out of 6 patients, the implantation was repeated successfully at a later time. Complication rates were 1.4 % (0.0512/1.000 catheter days) for peri-interventional, 2.9 % (0.081 per 1,000 catheter days) for early and 8.3 % (0.2288 per 1,000 catheter days) for late complications. The radiologist's experience level and vein selection did not have a significant impact. Most peri-interventional complications (82.4 %) were of minor severity. The early (61.5 %) and late (65.6 %) complications were more frequently of major severity. Interventions to manage complications comprised port explanation in 46.9 %, conservative therapy in 17.4 % and interventional therapy in 12.2 %. At 1 and 3 months after port placement, the majority were satisfied or very satisfied with the interventional port implantation. Conclusions: Ultrasound-guided, fluoroscopically controlled implantation of TIVAPs is a safe procedure with low complication rates, high success rates and high patient satisfaction.
机译：背景：要回顾性评估与动力可注射的完全可植入的静脉接入装置（TiFaps）相关的成功率，Peri介入，早期和晚期并发症和患者满意度。患者和方法：2011年4月至2016年3月，1,169名患者植入了1,203次TiFaps。通过亚克拉夫或内部颈静脉进行超声引导，透视控制的植入。系统分析专注于成功港口植入率，血栓介入，早期和晚期并发症的频率以及植入放射科学家的经验如何影响这些参数。此外，在电话采访中给予102项研究患者的标准化问卷调查，以调查其港口植入的主观评级。结果：99.5％的TiFAP成功植入。在6名患者中有4例，在以后成功重复植入。在早期并发症的早期和8.3％（每1,000个导管昼度为0.081，每1,000个导管日为0.0512 / 1.000导管昼度）的并发症率为8.3％（每1,000个导管日为每1000个导管天数）。放射科医师的体验水平和静脉选择没有显着影响。大多数Peri-介入并发症（82.4％）严重程度。早期（61.5％）和晚期（65.6％）并发症更频繁地具有重大严重程度。治疗并发症的干预措施包括46.9％，保守疗法的港口解释，17.4％，介入治疗12.2％。在港口安置后的1和3个月，大多数人对介入港口植入感到满意或非常满意。结论：超声引导，荧光透视控制的TiFAP植入是一种安全性，并复杂化率低，成功率高，患者满意度高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号